DRD2 and neuroendocrine neoplasm: Overexpression of DRD2 has been found in gastric cancer, neuroendocrine tumors, glioblastoma, breast cancer, cervical cancer, and colorectal cancer, and have variable association with survival with each histologic subtype (29, 30).